RCM
IDXX icon

Raleigh Capital Management’s Idexx Laboratories IDXX Stock Holding History

Raleigh Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41
Closed -$17.2K – 669
2025
Q1 		$17.2K Sell
41
-6
-13% -$2.6K 0.01% 331
2024
Q4 		$19.4K Sell
47
-3
-6% -$1.32K 0.01% 456
2024
Q3 		$25.3K Sell
50
-5
-9% -$2.43K 0.01% 412
2024
Q2 		$26.6K Buy
55
+1
+2% +$502 0.01% 389
2024
Q1 		$29.2K Sell
54
-18
-25% -$9.84K 0.01% 376
2023
Q4 		$39.8K Buy
72
+14
+24% +$6.57K 0.02% 309
2023
Q3 		$25.2K Buy
58
+1
+2% +$499 0.01% 361
2023
Q2 		$28.5K Sell
57
-8
-12% -$3.83K 0.01% 322
2023
Q1 		$32.5K Buy
+65
New +$31.1K 0.02% 303

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Raleigh Capital Management's IDXX Position: Q2 2025 in Review

Raleigh Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 41 shares — an estimated $17.2K sold.

Raleigh Capital Management first reported a position in IDXX in Q1 2023 and held it in 9 quarters. The position peaked at $39.8K in Q4 2023. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Raleigh Capital Management reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 41 Idexx Laboratories shares in Q2 2025, an estimated $17.2K.
  • Raleigh Capital Management first reported a position in Idexx Laboratories in Q1 2023 and held it in 9 quarters.
  • Raleigh Capital Management's Idexx Laboratories position peaked at $39.8K in Q4 2023.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Raleigh Capital Management's 13F filing for Q2 2025, filed 17 Jul 2025.